Back to search

University of British Columbia

Quantitative measurements of Rhenium-188 for radionuclide therapies

Abstract

dc:description

Over the last three decades, Rhenium-188 (¹⁸⁸Re) applications in Nuclear Medicine therapies have gathered a lot of interest thanks to the favorable physical and chemical characteristics of this isotope. In order to optimize ¹⁸⁸Re therapies, the accurate knowledge of the activity distribution within the patient body is required. To this end, the nuclear medicine images must yield accurate quantitative measurements. However, the decay of ¹⁸⁸Re results in a large variety of emissions such as β-particles, γ-particles and Bremsstrahlung, making quantitative measurements of ¹⁸⁸Re activity a very difficult task. The objective of this thesis was to develop a series of methods which would allow us to perform accurate measurements of ¹⁸⁸Re activities in the nuclear medicine department. To address the thesis’ objective, four major studies were carried out: 1) to ensure that measurements of patients administered activities are accurate, a practical method to determine dose-calibrator dial settings using a thyroid-probe was developed; 2) to assess the influence of ¹⁸⁸Re multiple emissions on quantitative imaging, a series of Monte-Carlo simulations of ¹⁸⁸Re single photon emission computed tomography (SPECT) were performed; 3) to assess the image quality and image quantification accuracy of a pre-clinical SPECT camera based on multi-pinhole collimators, a series of experiments using phantoms filled with ¹⁸⁸Re were performed and; 4) to investigate the accuracy of quantitative ¹⁸⁸Re SPECT using a clinical system as well as the accuracy of image-based dosimetry calculations in the context of ¹⁸⁸Re radioembolization, a series of phantom experiments and Monte-Carlo simulations were performed. The proposed thyroid-probe method enabled us to determine dose-calibrator settings for ¹⁸⁸Re which resulted in measurements of activity within 5% of the sample’s true value. The analysis of Monte-Carlo simulations indicated that Bremsstrahlung photons emitted from ¹⁸⁸Re do not really affect image-quantification. The results from phantom experiments showed that accurate quantification of Re-188 activities is possible in pre-clinical and clinical SPECT when images are reconstructed with iterative algorithms and corrections for attenuation, scatter using the triple-energy window method, resolution loss and dead-time. Due to the sub-optimal segmentation methods, dosimetry calculations based on ¹⁸⁸Re images underestimated the true dose by 15-20%, on average.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Physics
Grantor dc:publisher
University of British Columbia
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Esquinas Fernández, Pedro Luis

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/62139

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Esquinas Fernández, Pedro Luis. Quantitative measurements of Rhenium-188 for radionuclide therapies. doctoral thesis, University of British Columbia, 2017. http://hdl.handle.net/2429/62139